These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4791547)

  • 1. [Cicatrization of lesions of cutaneous American leishmaniasis with a single dose of cicloguanil pamoate].
    Gusmão HH; de Souza JA
    Rev Saude Publica; 1973 Dec; 7(4):335-41. PubMed ID: 4791547
    [No Abstract]   [Full Text] [Related]  

  • 2. American cutaneous leishmaniasis. Inefficacy of metronidazole in treatment.
    Walton BC; Paulson JE; Arjona MA; Peterson CA
    JAMA; 1974 Jun; 228(10):1256-8. PubMed ID: 4406512
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of cutaneous leishmaniasis (Leishmania tropica) with cycloguanil pamoate].
    Reinhard M; Wacker H
    Dtsch Med Wochenschr; 1970 Nov; 95(47):2380-2. PubMed ID: 5481970
    [No Abstract]   [Full Text] [Related]  

  • 4. Mucosal leishmaniasis and miltefosine.
    Tuon FF; Amato VS
    Clin Infect Dis; 2007 Jun; 44(11):1525-6; author reply 1526-7. PubMed ID: 17479959
    [No Abstract]   [Full Text] [Related]  

  • 5. [Leishmaniasis treatment].
    Minodier P; Jurquet AL; Noël G; Uters M; Laporte R; Garnier JM
    Arch Pediatr; 2010 Jun; 17(6):838-9. PubMed ID: 20654919
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of canine cutaneous leishmaniasis.
    Nicoletti P; Fruin J
    Trop Anim Health Prod; 1974 May; 6(2):85-8. PubMed ID: 4416718
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of intralesional meglumine antimoniate in the treatment of mucosal leishmaniasis of the Old World.
    Zaraa I; Karoui S; Osman AB
    J Dermatol; 2012 Feb; 39(2):201-3. PubMed ID: 21950659
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of American dermal leishmaniasis with cycloguanil pamoate.
    Pena Chavarria A; Kotcher E; Lizano C
    Trans R Soc Trop Med Hyg; 1968; 62(4):550-5. PubMed ID: 5671542
    [No Abstract]   [Full Text] [Related]  

  • 9. Itraconazole in the treatment of New World mucocutaneous leishmaniasis.
    Calvopina M; Guevara AG; Armijos RX; Hashiguchi Y; Davidson RN; Cooper PJ
    Int J Dermatol; 2004 Sep; 43(9):659-63. PubMed ID: 15357745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors associated with dizziness during treatment of mucosal leishmaniasis with meglumine antimoniate: 16-year retrospective study of cases from Rio de Janeiro, Brazil.
    Araujo-Melo MH; Meneses AM; Schubach AO; Moreira JS; Conceição-Silva F; Salgueiro MM; Pimentel MI; Araújo-Silva M; Oliveira RV; Carmo CN; Valete-Rosalino CM
    J Laryngol Otol; 2010 Oct; 124(10):1056-60. PubMed ID: 20537206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on: Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns.
    Dorlo TP; Kager PA
    Trans R Soc Trop Med Hyg; 2010 Jan; 104(1):84-5; author reply 85. PubMed ID: 19836815
    [No Abstract]   [Full Text] [Related]  

  • 12. Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.
    Guery R; Henry B; Martin-Blondel G; Rouzaud C; Cordoliani F; Harms G; Gangneux JP; Foulet F; Bourrat E; Baccard M; Morizot G; Consigny PH; Berry A; Blum J; Lortholary O; Buffet P;
    PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006094. PubMed ID: 29155816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucocutaneous leishmaniasis treated with liposomal amphotericin B.
    Lambertucci JR; Silva LC
    Rev Soc Bras Med Trop; 2008; 41(1):87-8. PubMed ID: 18368279
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of mucosal leishmaniasis with amphotericin B lipid complex (ABLC).
    Tuon FF; Santos CR; Cieslinski J; Souza RM; Imamura R; Amato VS
    Rev Inst Med Trop Sao Paulo; 2018 Nov; 60():e71. PubMed ID: 30427406
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of extended (six weeks) treatment with miltefosine for mucosal leishmaniasis in Bolivia.
    Soto J; Rea J; Valderrama M; Toledo J; Valda L; Ardiles J; Berman J
    Am J Trop Med Hyg; 2009 Sep; 81(3):387-9. PubMed ID: 19706901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of mucocutaneous leishmaniasis with pentamidine isothionate].
    Amato V; Amato J; Nicodemo A; Uip D; Amato-Neto V; Duarte M
    Ann Dermatol Venereol; 1998 Aug; 125(8):492-5. PubMed ID: 9747313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intralesional glucantime in Leishmania braziliensis braziliensis infections.
    Barrios LA; Costa JM; Netto EM; Vexenat CO; Cuba CC; Marsden PD
    Trans R Soc Trop Med Hyg; 1986; 80(1):173-4. PubMed ID: 3726989
    [No Abstract]   [Full Text] [Related]  

  • 18. A field trial of the effectiveness of cycloguanil pamoate in Rhodesia.
    Harwin RM
    Cent Afr J Med; 1973 Jan; 19(1):9-12. PubMed ID: 4576484
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical Paromomycin for treating solitary mucosal leishmaniasis.
    Kassem R; Peretz A; Porat Ben Amy D
    Int J Dermatol; 2018 Jun; 57(6):721-723. PubMed ID: 29377089
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of cutaneous leishmaniasis with cycloguanil pamoate.
    Ardehali M
    Int J Dermatol; 1974; 13(1):26-8. PubMed ID: 4813519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.